This study emphasizes the advantages of MSC-EXOs as a therapeutic modality in the context of regenerative medicine for asthma treatment. Preclinical studies have consistently demonstrated the therapeutic potential of MSC-EXOs, suggesting that they may provide additional treatment options for asthma patients in the future.
No takes yet. Share an insight, caveat, or question.
Suo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: